Counterpoint Mutual Funds’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,817
Closed -$323K – 426
2026
Q2
$323K Buy
+3,817
New +$308K 0.03% 233
2026
Q1
– Sell
-3,563
Closed -$281K – 417
2025
Q4
$281K Sell
3,563
-596
-14% -$47.2K 0.02% 316
2025
Q3
$343K Sell
4,159
-4,651
-53% -$366K 0.03% 272
2025
Q2
$708K Buy
8,810
+4,690
+114% +$362K 0.06% 102
2025
Q1
$331K Buy
+4,120
New +$343K 0.05% 260
2022
Q4
– Sell
-3,870
Closed -$235K – 379
2022
Q3
$235K Buy
+3,870
New +$247K 0.57% 21

Other funds holding MET

Counterpoint Mutual Funds's MET Position: Q3 2026 in Review

Counterpoint Mutual Funds sold out of MetLife (MET) in Q3 2026, closing a stake of 3,817 shares — an estimated $323K sold.

Counterpoint Mutual Funds first reported a position in MET in Q3 2022 and held it in 6 quarters. The position peaked at $708K in Q2 2025. 989 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Counterpoint Mutual Funds reported no remaining MetLife position as of Q3 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 3,817 MetLife shares in Q3 2026, an estimated $323K.
  • Counterpoint Mutual Funds first reported a position in MetLife in Q3 2022 and held it in 6 quarters.
  • Counterpoint Mutual Funds's MetLife position peaked at $708K in Q2 2025.
  • 989 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.